Hal Barron (GSK via YouTube)
GSK declares a big win with positive topline results for its adult RSV vaccine. But the jury's still out on bottom line efficacy
Emma Walmsley’s bet on making GSK a pure play Big Pharma innovator just cleared a major milestone. But the GSK team is not home free …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
